{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:40:06Z","timestamp":1758937206194,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.leukres.2019.106227","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:10:07Z","timestamp":1568718607000},"page":"106227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts"],"prefix":"10.1016","volume":"86","author":[{"given":"Zhining","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maitrayee","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Routbort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5081-2427","authenticated-orcid":false,"given":"Keyur P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajyalakshmi","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-7880","authenticated-orcid":false,"given":"Chi Young","family":"Ok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.leukres.2019.106227_bib0005","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.13405","article-title":"Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts","volume":"93","author":"Mufti","year":"2008","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.leukres.2019.106227_bib0010","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.leukres.2011.04.021","article-title":"Transient\/reversible ring sideroblasts in bone marrow of patients post cytotoxic therapies for primary malignancies","volume":"35","author":"Ok","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2019.106227_bib0015","series-title":"World Health Organization Classification of Tumours","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"issue":"2","key":"10.1016\/j.leukres.2019.106227_bib0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molcel.2006.05.037","article-title":"Direct interactions between subunits of CPSF and the U2 snRNP contribute to the coupling of pre-mRNA 3\u2032 end processing and splicing","volume":"23","author":"Kyburz","year":"2006","journal-title":"Mol. Cell"},{"issue":"15","key":"10.1016\/j.leukres.2019.106227_bib0025","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.leukres.2019.106227_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","article-title":"SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts","volume":"126","author":"Malcovati","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2019.106227_bib0035","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1038\/ncomms6901","article-title":"Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes","volume":"6","author":"Gerstung","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.leukres.2019.106227_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126555","article-title":"Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts","volume":"10","author":"del Rey","year":"2015","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.leukres.2019.106227_bib0045","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1182\/blood-2012-03-415356","article-title":"Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts","volume":"119","author":"Patnaik","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2019.106227_bib0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/leu.2013.191","article-title":"Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia","volume":"28","author":"Ok","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2019.106227_bib0055","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.leukres.2014.12.006","article-title":"Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases","volume":"39","author":"Ok","year":"2015","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.leukres.2019.106227_bib0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(16)30626-X","article-title":"Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol."},{"issue":"7540","key":"10.1016\/j.leukres.2019.106227_bib0065","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.leukres.2019.106227_bib0070","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"year":"2016","series-title":"An International System for Human Cytogenomic Nomenclature","author":"McGowan-Jordan","key":"10.1016\/j.leukres.2019.106227_bib0075"},{"issue":"2","key":"10.1016\/j.leukres.2019.106227_bib0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3324\/haematol.2018.191148","article-title":"Persistent IDH1\/2 mutations in remission can predict relapse in patients with acute myeloid leukemia","volume":"104","author":"Ok","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2019.106227_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-019-0479-8","article-title":"The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution","author":"Singhal","year":"2019","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.leukres.2019.106227_bib0090","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2012-05-430876","article-title":"SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes","volume":"120","author":"Visconte","year":"2012","journal-title":"Blood"},{"issue":"7367","key":"10.1016\/j.leukres.2019.106227_bib0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212619301729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212619301729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:59:42Z","timestamp":1758934782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212619301729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":19,"alternative-id":["S0145212619301729"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2019.106227","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2019.106227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106227"}}